Protease-antiprotease imbalance may be linked to potential defects in profilaggrin proteolysis in atopic dermatitis

British Journal of Dermatology

Volumn 166, Issue 5, 2012, Pages 1137-1140

  Tan, S P ^a,b   Abdul Ghaffar, S ^c   Weller, R B ^a,b   Brown, S B ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGENIC SUBSTRATE; CHYMOTRYPSIN; CYTOKERATIN 8; ELAFIN; ELASTASE; MACROGOL; MATRIPTASE; MONOCLONAL ANTIBODY; MONOMER; PAPAIN; PROFILAGGRIN; PROTEIN PRECURSOR; PROTEINASE; PROTEINASE INHIBITOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TRYPSIN;

ADULT; ATOPIC DERMATITIS; BLISTER; CENTRIFUGATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FILAGGRIN GENE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SUCTION; SUSPENSION; WESTERN BLOTTING; WILD TYPE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; MALE; MIDDLE AGED; MUTATION; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; PROTEOLYSIS; YOUNG ADULT;

EID: 84860339522     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10750.x     Document Type: Letter

References (11)

1. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-6.
2. Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2009; 3 (Suppl. 2): R7-12.
3. Sandilands A, Sutherland C, Irvine AD, McLean WHI,. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 2009; 122: 1285-94.
4. List K, Szabo R, Wertz PW, et al. Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. J Cell Biol 2003; 163: 901-10. (Pubitemid 37517896)
5. List K, Bugge TH, Szabo R,. Matriptase: potent proteolysis on the cell surface. Mol Med 2006; 12: 1-7. (Pubitemid 44128372)
6. Sandilands A, Terron-Kwiatkowski A, Hull PR, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007; 39: 650-4. (Pubitemid 46676107)
7. Groth S, Staberg B,. Suction blisters of the skin: a compartment with physiological, interstitium-like properties. Scand J Clin Lab Invest 1984; 44: 311-16. (Pubitemid 14111535)
8. Vasilopoulos Y, Cork MJ, Murphy R, et al. Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 2004; 123: 62-6. (Pubitemid 38833464)
9. Wiedow O, Wiese F, Streit V, et al. Lesional elastase activity in psoriasis, contact dermatitis, and atopic dermatitis. J Invest Dermatol 1992; 99: 306-9.
10. Hachem JP, Man MQ, Crumrine D, et al. Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol 2005; 125: 510-20.
11. Descargues P, Deraison C, Bonnart C, et al. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 2005; 37: 56-65. (Pubitemid 40070940)